Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 60% of the road = 270-days

<< Previous

Bullboard Posts

Next >>

Comment by CancerSlayeron Jul 14, 2022 10:49pm

288 Views

Post# 34825859

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:60% of the road = 270-days

Hi Yajne...thanks. All the currently approved commercial vaccines are systemically administered & completely bypass the airway. The potential advantage of using an intranasal vaccine is that it can induce both airway/mucosal & systemic immunity (both antibody-mediated & cell-mediated). It also has the additional advantage of ease of administration...no shot required, which can be an issue with the needle-phobic & kids. Eventually, perhaps a shot and sniff could be utilized down the road to further maximize efficacy if needed ; )

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle